Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ERAS

ERAS News

Newswire

09:51

Precision Oncology Sector Sees Transformation with Biomarker-Driven Therapies and Immunotherapies.

16:25

Erasca shares surge 11.05% after-hours as analysts set $4.00 consensus target price.

09:35

Guggenheim Maintains Buy on Erasca, Raises PT to $5 from $3

17:09

Erasca shares surge 11.44% after-hours after securing 2043 U.S. patent for ERAS-0015 and disclosing 2026 Phase 1 data milestones.

16:39

Erasca Reports Flat Q3 Net Loss, Focused on Precision Oncology Pipeline

View More

About ERAS

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More